Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave's Q4 Revenues Rise 17-Percent; 85 Percent of '07 Receipts to Come From Dxs

NEW YORK (GenomeWeb News) — Third Wave Technologies today said fourth-quarter revenues increased 17 percent as R&D spending nearly doubled and net loss narrowed 8 percent.  
Total receipts for the three months ended Dec. 31, 2006, increased to $6.8 million from $5.8 million year over year.
Revenue from molecular diagnostics rose to $5.8 million from $4.3 million, but receipts from research products declined to $954,000 from $2.4 million.
R&D expenses doubled to $3.6 million compared with $1.8 million the previous year.
CEO Kevin Conroy said the company “met or exceeded” its 2006 objectives and said it met its product-development goals for the year, including starting clinical trials for HPV products and submitting a cystic fibrosis diagnostic test for FDA approval.
Net loss for the periods declined to $4.6 million from $5 million year over year.
Third Wave had around $44.2 million in cash, cash equivalents, and short-term investments as of Dec. 31.
The company said it expects 2007 revenue to be between $31 million and $33 million, or an improvement of between 10.7 percent and 17.8 percent year over year. Third Wave said that between $26 million and $28 million of this year’s revenue will come from molecular diagnostics.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.